|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.72 NOK | -1.04% |
|
+7.92% | +17.70% |
Lytix Biopharma AS reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was NOK 3.99 million compared to NOK 1.41 million a year ago. Revenue was NOK 10.24 million compared to NOK 17.27 million a year ago.
Net loss was NOK 87.94 million compared to NOK 56.01 million a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +17.70% | 20.75M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
LYTIX BIOPHARMA 
